These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. Sehayek E; Eisenberg S J Biol Chem; 1991 Sep; 266(27):18259-67. PubMed ID: 1917954 [TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. Bradley WA; Hwang SL; Karlin JB; Lin AH; Prasad SC; Gotto AM; Gianturco SH J Biol Chem; 1984 Dec; 259(23):14728-35. PubMed ID: 6501314 [TBL] [Abstract][Full Text] [Related]
4. Cellular metabolism of human plasma intermediate-density lipoprotein (IDL). Friedman G; Gavish D; Vogel T; Eisenberg S Biochim Biophys Acta; 1990 May; 1044(1):118-26. PubMed ID: 2340301 [TBL] [Abstract][Full Text] [Related]
5. Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia. Turner PR; Cortese C; Wootton R; Marenah C; Miller NE; Lewis B Eur J Clin Invest; 1985 Apr; 15(2):100-12. PubMed ID: 3922766 [TBL] [Abstract][Full Text] [Related]
6. Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lys146-->Gln) are inefficiently converted to cholesterol-rich lipoproteins. Mulder M; van der Boom H; de Knijff P; Braam C; van den Maagdenberg A; Leuven JA; Havekes LM Atherosclerosis; 1994 Aug; 108(2):183-92. PubMed ID: 7980718 [TBL] [Abstract][Full Text] [Related]
7. Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice. Auger A; Truong TQ; Rhainds D; Lapointe J; Letarte F; Brissette L Eur J Biochem; 2001 Apr; 268(8):2322-30. PubMed ID: 11298750 [TBL] [Abstract][Full Text] [Related]
8. Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency. Ikewaki K; Cain W; Thomas F; Shamburek R; Zech LA; Usher D; Brewer HB; Rader DJ J Lipid Res; 2004 Jul; 45(7):1302-11. PubMed ID: 15102883 [TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridemia: lipoprotein receptors and atherosclerosis. Gianturco SH; Gotto AM; Bradley WA Adv Exp Med Biol; 1985; 183():47-71. PubMed ID: 4036704 [TBL] [Abstract][Full Text] [Related]
11. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells. Krämer-Guth A; Nauck M; Pavenstädt H; Königer M; Wieland H; Schollmeyer P; Wanner C J Am Soc Nephrol; 1994 Oct; 5(4):1081-90. PubMed ID: 7849247 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis. Huff MW; Breckenridge WC; Strong WL; Wolfe BM Arteriosclerosis; 1988; 8(5):471-9. PubMed ID: 3190554 [TBL] [Abstract][Full Text] [Related]
13. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028 [TBL] [Abstract][Full Text] [Related]
14. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway. Hakamata H; Sakaguchi H; Zhang C; Sakashita N; Suzuki H; Miyazaki A; Takeya M; Takahashi K; Kitamura N; Horiuchi S Biochemistry; 1998 Sep; 37(39):13720-7. PubMed ID: 9753460 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of apoB-100 in lipoproteins separated by density gradient ultracentrifugation in normal and Watanabe heritable hyperlipidemic rabbits. Shames DM; Yamada N; Havel RJ J Lipid Res; 1990 May; 31(5):753-62. PubMed ID: 2380627 [TBL] [Abstract][Full Text] [Related]
17. Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin. Zhao SP; Smelt AH; Van den Maagdenberg AM; Van Tol A; Vroom TF; Gevers Leuven JA; Frants RR; Havekes LM; Van der Laarse A; Van 't Hooft FM Arterioscler Thromb; 1994 Nov; 14(11):1705-16. PubMed ID: 7947593 [TBL] [Abstract][Full Text] [Related]
18. The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL. Fisher WR; Zech LA; Bardalaye P; Warmke G; Berman M J Lipid Res; 1980 Aug; 21(6):760-74. PubMed ID: 7419987 [TBL] [Abstract][Full Text] [Related]
19. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. Teng B; Sniderman AD; Soutar AK; Thompson GR J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973 [TBL] [Abstract][Full Text] [Related]
20. Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits. Yamada N; Shames DM; Havel RJ J Clin Invest; 1987 Aug; 80(2):507-15. PubMed ID: 3611356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]